April 30, 2020

Extramurally Funded Research Grants Awarded to Cancer Bio Faculty Members

From Translational and Clinical Research

Partnering primary investigators, Sofia Merajver, M.D., Ph.D., and Goutham Narla, M.D., Ph.D., received two inter-programmatic Department of Defense Breast Cancer Research Program Breakthrough Awards. The three year awards, totaling $2.3M, study the therapeutic reactivation of the PP2A tumor suppressor for breast cancer treatment.


$100K+ Grants Awarded in March


Joshi Alumkal, M.D.: P50 SubK [Overall PI: Peter Nelson (Fred Hutchinson Cancer Research Center)] ($132K) “Targeting Emerging Vulnerabilities in AR-Independent Prostate Cancer” (DT)
Howard Crawford, Ph.D.: R01 ($2.4M) "Metaplastic Tuft Cells in Pancreatic Cancer" (CB)
Meredith Morgan, Ph.D.: R01 ($2.3M) "Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer" (DT)

Other External 

Costas Lyssiotis, Ph.D.: $200K SubK from Cornell University (Prime Sponsor: The Mark Foundation for Cancer Research) for “Malic enzyme dependence is a therapeutic vulnerability in pancreatic cancer” (CB)